
Stephen L. Rawlings
Examiner (ID: 18470, Phone: (571)272-0836 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1642, 1643, 1646 |
| Total Applications | 1483 |
| Issued Applications | 633 |
| Pending Applications | 153 |
| Abandoned Applications | 701 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10234966
[patent_doc_number] => 20150119961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'Malignant Tumor Heat Therapy Kit Comprising Anti-Regulatory T Cell Antibody and Magnetic Fine Particles and Heat Therapy Method Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/576852
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3593
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14576852
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/576852 | Malignant Tumor Heat Therapy Kit Comprising Anti-Regulatory T Cell Antibody and Magnetic Fine Particles and Heat Therapy Method Thereof | Dec 18, 2014 | Abandoned |
Array
(
[id] => 10491244
[patent_doc_number] => 20150376265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'ANTIBODY COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/577991
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 38541
[patent_no_of_claims] => 102
[patent_no_of_ind_claims] => 54
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14577991
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/577991 | ANTIBODY COMPOSITIONS AND METHODS OF USE | Dec 18, 2014 | Abandoned |
Array
(
[id] => 10290707
[patent_doc_number] => 20150175706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'Novel Antibodies Against Cancer Target Block Tumor Growth, Angiogenesis and Metastatis'
[patent_app_type] => utility
[patent_app_number] => 14/571801
[patent_app_country] => US
[patent_app_date] => 2014-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15815
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14571801
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/571801 | Novel Antibodies Against Cancer Target Block Tumor Growth, Angiogenesis and Metastatis | Dec 15, 2014 | Abandoned |
Array
(
[id] => 10240482
[patent_doc_number] => 20150125478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS'
[patent_app_type] => utility
[patent_app_number] => 14/562156
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 46092
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562156
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/562156 | Immunotherapy against several tumors including neuronal and brain tumors | Dec 4, 2014 | Issued |
Array
(
[id] => 10354977
[patent_doc_number] => 20150239983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'HIGH AFFINITY ANTI-PROSTATE STEM CELL ANTIGEN (PSCA) ANTIBODIES FOR CANCER TARGETING AND DETECTION'
[patent_app_type] => utility
[patent_app_number] => 14/562269
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 12114
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562269
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/562269 | High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection | Dec 4, 2014 | Issued |
Array
(
[id] => 11351525
[patent_doc_number] => 20160370265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'METHOD FOR ISOLATING EXOSOMES'
[patent_app_type] => utility
[patent_app_number] => 15/100931
[patent_app_country] => US
[patent_app_date] => 2014-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7847
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15100931
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/100931 | METHOD FOR ISOLATING EXOSOMES | Dec 2, 2014 | Abandoned |
Array
(
[id] => 10283426
[patent_doc_number] => 20150168424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'IGFBP2 Biomarker'
[patent_app_type] => utility
[patent_app_number] => 14/556402
[patent_app_country] => US
[patent_app_date] => 2014-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25508
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14556402
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/556402 | IGFBP2 Biomarker | Nov 30, 2014 | Abandoned |
Array
(
[id] => 9900935
[patent_doc_number] => 20150056135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'Treatment of Proliferative Disorders Using Antibodies to PSMA'
[patent_app_type] => utility
[patent_app_number] => 14/537002
[patent_app_country] => US
[patent_app_date] => 2014-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17019
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14537002
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/537002 | Treatment of Proliferative Disorders Using Antibodies to PSMA | Nov 9, 2014 | Abandoned |
Array
(
[id] => 10254989
[patent_doc_number] => 20150139986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'ILT3 BINDING MOLECULES AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/527834
[patent_app_country] => US
[patent_app_date] => 2014-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23903
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14527834
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/527834 | ILT3 BINDING MOLECULES AND USES THEREFOR | Oct 29, 2014 | Abandoned |
Array
(
[id] => 11348911
[patent_doc_number] => 20160367651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'T CELL INDUCING VACCINE CONTAINING AN INTEREPITOPE SEQUENCE THAT PROMOTES ANTIGEN PRESENTATION'
[patent_app_type] => utility
[patent_app_number] => 15/026841
[patent_app_country] => US
[patent_app_date] => 2014-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10502
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026841
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/026841 | T CELL INDUCING VACCINE CONTAINING AN INTEREPITOPE SEQUENCE THAT PROMOTES ANTIGEN PRESENTATION | Sep 30, 2014 | Abandoned |
Array
(
[id] => 11888033
[patent_doc_number] => 09758584
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-12
[patent_title] => 'Biological materials related to CXCR7'
[patent_app_type] => utility
[patent_app_number] => 14/501426
[patent_app_country] => US
[patent_app_date] => 2014-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 41446
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14501426
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/501426 | Biological materials related to CXCR7 | Sep 29, 2014 | Issued |
Array
(
[id] => 10208408
[patent_doc_number] => 20150093398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'Methods and Compositions for Treating or Preventing Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/487659
[patent_app_country] => US
[patent_app_date] => 2014-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19666
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14487659
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/487659 | Methods and Compositions for Treating or Preventing Cancer | Sep 15, 2014 | Abandoned |
Array
(
[id] => 9910182
[patent_doc_number] => 20150065383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'METHOD FOR DETECTING CERVICAL DYSPLASIA'
[patent_app_type] => utility
[patent_app_number] => 14/480546
[patent_app_country] => US
[patent_app_date] => 2014-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16645
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14480546
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/480546 | Method for detecting cervical dysplasia | Sep 7, 2014 | Issued |
Array
(
[id] => 10593466
[patent_doc_number] => 09314537
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => 'SPARC binding ScFcs'
[patent_app_type] => utility
[patent_app_number] => 14/451858
[patent_app_country] => US
[patent_app_date] => 2014-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17612
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14451858
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/451858 | SPARC binding ScFcs | Aug 4, 2014 | Issued |
Array
(
[id] => 10586683
[patent_doc_number] => 09308279
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'SPARC binding ScFvs'
[patent_app_type] => utility
[patent_app_number] => 14/451008
[patent_app_country] => US
[patent_app_date] => 2014-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17582
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14451008
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/451008 | SPARC binding ScFvs | Aug 3, 2014 | Issued |
Array
(
[id] => 10990399
[patent_doc_number] => 20160187343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING A RISK OF CANCER IN A SUBJECT'
[patent_app_type] => utility
[patent_app_number] => 14/908822
[patent_app_country] => US
[patent_app_date] => 2014-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23403
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908822
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/908822 | COMPOSITIONS AND METHODS FOR IDENTIFYING A RISK OF CANCER IN A SUBJECT | Jul 30, 2014 | Abandoned |
Array
(
[id] => 10966984
[patent_doc_number] => 20140370016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'SPARC BINDING SCFVS'
[patent_app_type] => utility
[patent_app_number] => 14/448696
[patent_app_country] => US
[patent_app_date] => 2014-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17547
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14448696
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/448696 | SPARC binding ScFcs | Jul 30, 2014 | Issued |
Array
(
[id] => 11415252
[patent_doc_number] => 09562070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-07
[patent_title] => 'Induction of tumor immunity by variants of folate binding protein'
[patent_app_type] => utility
[patent_app_number] => 14/339797
[patent_app_country] => US
[patent_app_date] => 2014-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 39710
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14339797
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/339797 | Induction of tumor immunity by variants of folate binding protein | Jul 23, 2014 | Issued |
Array
(
[id] => 11785014
[patent_doc_number] => 09394359
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-19
[patent_title] => 'Methods and agents for the diagnosis and treatment of hepatocellular carcinoma'
[patent_app_type] => utility
[patent_app_number] => 14/336441
[patent_app_country] => US
[patent_app_date] => 2014-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 153
[patent_figures_cnt] => 186
[patent_no_of_words] => 31796
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336441
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/336441 | Methods and agents for the diagnosis and treatment of hepatocellular carcinoma | Jul 20, 2014 | Issued |
Array
(
[id] => 10979999
[patent_doc_number] => 20160176943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'NOVEL ALTERNATIVE SPLICE TRANSCRIPTS FOR MHC CLASS I RELATED CHAIN ALPHA (MICA) AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/902615
[patent_app_country] => US
[patent_app_date] => 2014-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 32349
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14902615
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/902615 | NOVEL ALTERNATIVE SPLICE TRANSCRIPTS FOR MHC CLASS I RELATED CHAIN ALPHA (MICA) AND USES THEREOF | Jul 3, 2014 | Abandoned |